VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 9021 · 118th Congress

No Tax Breaks for Drug Ads Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 118th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

4 cosponsors · 4 D

2 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill disallows any tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs.

What it does: CRS summary · Introduced in House · Jul 11, 2024

No Tax Breaks for Drug Ads Act

This bill disallows any tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: No Tax Breaks for Drug Ads Act

Latest action (Jul 11, 2024): Referred to the House Committee on Ways and Means.

Policy area: Taxation · Origin: House · Introduced: Jul 11, 2024

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.